Biodistribution of a low dose of intravenously administered AAV-2, 10, and 11 vectors to cynomolgus monkeys

Japanese Journal of Infectious Diseases

Volumn 59, Issue 5, 2006, Pages 285-293

  Mori, Seiichiro ^a   Takeuchi, Takamasa ^a   Enomoto, Yutaka ^a   Kondo, Kazunari ^a   Sato, Kaori ^a   Ono, Fumiko ^b   Iwata, Naoko ^a   Sata, Tetsutaro ^a   Kanda, Tadahito ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b The Corporation for Production and Research of Laboratory Primates   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BETA GALACTOSIDASE; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 10; ADENO ASSOCIATED VIRUS 11; ADENO ASSOCIATED VIRUS 2; AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY DISTRIBUTION; BRAIN TISSUE; CIRCULATION; COLON; CONTROLLED STUDY; FEMALE; GALLBLADDER; GENE EXPRESSION; GENE TRANSFER; HEART; INOCULATION; INTRAVENOUS ADMINISTRATION; LIVER PARENCHYMA; LUNG PARENCHYMA; LYMPH NODE; LYMPHOID TISSUE; MALE; MONKEY; NONHUMAN; OVARY; PANCREAS; POLYMERASE CHAIN REACTION; SAFETY; SEROTYPE; SPLEEN; TRANSGENE; UTERUS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BETA-GALACTOSIDASE; CERCOPITHECUS AETHIOPS; COS CELLS; DEPENDOVIRUS; DNA; FEMALE; GENE FUSION; GENE THERAPY; GENES, ERBB-1; GENETIC VECTORS; INJECTIONS, INTRAVENOUS; LYMPH NODES; MACACA FASCICULARIS; MALE; MICE; RECOMBINANT FUSION PROTEINS; SPLEEN; TISSUE DISTRIBUTION; TUBULIN;

EID: 33750437255     PISSN: 13446304     EISSN: 13446304     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Muzyczka, N. and Berns, K.I. (2001): Parvoviridae: The viruses and their replication. p. 2327-2359. In D.M. Knipe and P.M. Howley (ed.), Fields Virology. vol. 2. Lippincott Williams & Wilkins, Philadelphia.
2. Zolotukhin, S. (2005): Production of recombinant adeno-associated virus vectors. Hum. Gene Ther., 16, 551-557.
3. Grimm, D. and Kay, M.A. (2003): From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther., 3, 281-304.
4. Tenenbaum, L., Lehtonen, E. and Monahan, P.E. (2003): Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr. Gene Ther., 3, 545-565.
5. McCarty, D.M., Young, S.M., Jr. and Samulski, R.J. (2004): Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet., 38, 819-845.
6. Conrad, C.K., Allen, S.S., Afione, S.A., Reynolds, T.C., Beck, S.E., Fee-Maki, M., Barrazza-Ortiz, X., Adams, R., Askin, F.B., Carter, B.J., Guggino, W.B. and Flotte, T.R. (1996): Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther., 3, 658-668.
7. Favre, D., Provost, N., Blouin, V., Blancho, G., Cherel, Y., Salvetti, A. and Moullier, P. (2001): Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. Mol. Ther., 4, 559-566.
8. Lai, L., Davison, B.B., Veazey, R.S., Fisher, K.J. and Baskin, G.B. (2002): A preliminary evaluation of recombinant adeno-associated virus biodistribution in rhesus monkeys after intrahepatic inoculation in utero. Hum. Gene Ther., 13, 2027-2039.
9. Nathwani, A.C., Davidoff, A.M., Hanawa, H., Hu, Y., Hoffer, F.A., Nikanorov, A., Slaughter, C., Ng, C.Y., Zhou, J., Lozier, J.N., Mandrell, T.D., Vanin, E.F. and Nienhuis, A.W. (2002): Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood, 100, 1662-1669.
10. Davidoff, A.M., Gray, J.T., Ng, C.Y., Zhang, Y., Zhou, J., Spence, Y., Bakar, Y. and Nathwani, A.C. (2005): Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. Mol. Ther., 11, 875-888.
11. Provost, N., Le Meur, G., Weber, M., Mendes-Madeira, A., Podevin, G., Cherel, Y., Colle, M.A., Deschamps, J.Y., Moullier, P. and Rolling, F. (2005): Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain. Mol. Ther., 11, 275-283.
12. Mori, S., Wang, L., Takeuchi, T. and Kanda, T. (2004): Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virology, 330, 375-383.
13. Auricchio, A., Hildinger, M., O'Connor, E., Gao, G.P. and Wilson, J.M. (2001): Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther., 12, 71-76.
14. Zaiss, A.K. and Muruve, D.A. (2005): Immune responses to adeno-associated virus vectors. Curr. Gene Ther., 5, 323-331.
15. Vallee, R.B. and Bloom, G.S. (1983): Isolation of sea urchin egg microtubules with taxol and identification of mitotic spindle microtubule-associated proteins with monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 80, 6259-6263.